Concepedia

Sarah A. Sagi

SA

Statistics

Publications

14

Citations

3.7K

H-Index

14

Active since

2001

Affiliations

University of California San Diego(Current)

Jacksonville College

Mayo Clinic in Florida

WinnMed

Myriad Genetics

Sarah A. Sagi is an author at University of California San Diego specializing in pharmacology, amyloid formation, and neuropharmacology.

Publications per year

2001–2011

14

Publications

14

A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity

Sascha Weggen, Jason L. Eriksen, Pritam Das et al. · Nature · 2001 · 1.4K citations

, , +14

NSAIDs and enantiomers of flurbiprofen target γ-secretase and lower Aβ42 in vivo

Jason L. Eriksen, Sarah A. Sagi, Tawnya E. Smith et al. · Journal of Clinical Investigation · 2003 · 620 citations · Full text

, , +17

Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid β42 Production by Direct Modulation of γ-Secretase Activity

Sascha Weggen, Jason L. Eriksen, Sarah A. Sagi et al. · Journal of Biological Chemistry · 2003 · 287 citations · Full text

, , +17

Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production

Thomas Kukar, M. Paul Murphy, Jason L. Eriksen et al. · Nature Medicine · 2005 · 283 citations

, , +14

Substrate-targeting γ-secretase modulators

Thomas Kukar, Thomas B. Ladd, Maralyssa Bann et al. · Nature · 2008 · 278 citations · Full text

1–5 of 14